Tuesday, May 20, 2025
HomeIndustriesBiotechnology

Biotechnology

RegeneRx Partner Signs LOI with Global Ophthalmology CRO for Two Phase 3 Clinical Trials in Neurotrophic Keratitis

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting today that its U.S. joint venture (JV)...

Ginkgo Bioworks Announces Collaboration for Beauty and Personal Care Industry with Sumitomo Chemical

Ginkgo Bioworks, the leading horizontal platform for cell programming, announced the launch of a new cell programming project as part of a broader collaboration...

Brii Bio Announces Strategic Partnership with China Resources Pharmaceutical Commercial Group

Brii Biosciences Limited a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced that TSB...

GenScript ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs

GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and DAAN Bio Therapeutics (Byoung Chul Cho, Co-Founder & CEO), an innovative new drug developer...

U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Individuals Aged 18 and Over

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373)...
0FansLike
0FollowersFollow
spot_img

Hot Topics